The Pharma Cold Chain: More Visible, More Sustainable—and Colder
Although time has welcomed novel advances in the space, new challenges pertaining to data and the physical technology, along with visibility and sustainability, are emerging.
The State of the Pharma Cold Chain
While vendors fill in gaps in products and services for the supply chain, the action moves toward new cloud-based visibility systems.
Wholesalers Step Up Their Partnering
Companies' emphasis on delivering pharmaceuticals is evolving into a collaboration focused on healthcare outcomes.
Serialization Solution Provider Consolidation Continues: Advanco Acquires Vantage Solutions
Buyout gives Advanco a bigger US footprint.
New Trends in Sales Force Organization
The latest IT offerings for sales force automation—including new AI tools—promise a more effective pharma sales process.
Veeva Is Building Its Own Cloud Platform, Plus Other New Capabilities for Managing Life Sciences Sales and Marketing
A ‘next generation’ CRM platform will gradually leave the Salesforce.com platform behind.
IQVIA Study: Illegal Online Pharmacies Cost Pharma $34B in Diverted 2022 US Sales
“Deep learning” IT tools were used to calculate sales volumes and drug class.
Ramping Up DSCSA Readiness Efforts
As a November deadline looms for industry compliance with an interoperable system for product tracing, there is more urgency in the US pharma supply chain.
NABP Hopes to Fill a Key Gap in DSCSA Compliance: Local Pharmacies
The Pulse online service will provide free resources to enable pharmacy to meet drug traceability rules.
Pharma Cold Chain in Search of Equilibrium
Post-pandemic conditions are improving for the temperature-controlled market, but, meanwhile, the technical demands are rising.
Cold Chain Tech Continues to Evolve
The pandemic, which stressed all participants in the pharma cold chain, has not stopped innovation in industry practices, as exploration of the main drivers shows
Cryoport and Cell Matters to Collaborate on Standardizing Cell Therapy Supply Chain processes
Companies hope to combine their cryogenic expertise with dedicated packaging and supply chain services
Countdown to 2023 DSCSA Compliance
The clock is ticking on a massive effort to bring interoperable, electronic tracking of pharma shipments in the US
The Pulse of Rare Disease Support
Biopharma sponsorship of patient-support programs and treatments for rare diseases is growing, but gaps remain
Gilead’s case against an alleged $250-million counterfeiting ring—what happens next?
In a civil action, Gilead alleges an extensive, transnational counterfeiting ring of HIV and other drugs
Ups and downs in the march to DSCSA compliance
Building a data-sharing system for the US Drug Supply Chain Security Act (DSCSA) is two years from a mandated completion—will industry be ready?
Preserving Drug Sampling Activity
A dramatic shift to e-sampling has been the effective counter to the reduced number of rep visits to physicians’ offices
Where will the next life sciences business cluster grow?
State and regional economic-development authorities compete fiercely for siting new pharma enterprises, and holding onto the ones they have. But pharma’s stupendous growth in investment is giving all regions a boost
RFID on the rise again in pharma
Bypassed a decade ago for traceability applications, radio-frequency identification is making a comeback in hospital pharmacies
Covid-19 vaccine is here, but supplies will be tight
At best, 25 million doses might be available by year-end, sufficient for half that many Americans
Amazon Pharmacy is here; will it change the retail drug business?
Pillpack continues its drugs-for-the-day packaging, while parent Amazon works with Express Scripts on drug reimbursement
Progress on DSCSA compliance slows down in US pharma supply chain
FDA postpones compliance deadlines to 2023 while issuing new guidance on drug importation